Previous studies reported that in other tumor types, UBE2O mediates the degradation of AMPKα2 and TRAF6, thus affecting the AMPK and NFKB pathways, respectively, as well as EMT, DNA repair, and lipid metabolism [18, 25, 27, 33, 34]. This evidence concerns the gene NFKB1 and neoplasm.